These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 21059912

  • 1. Building multifunctionality into a complex containing master regulators of hematopoiesis.
    Fujiwara T, Lee HY, Sanalkumar R, Bresnick EH.
    Proc Natl Acad Sci U S A; 2010 Nov 23; 107(47):20429-34. PubMed ID: 21059912
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.
    Draheim KM, Hermance N, Yang Y, Arous E, Calvo J, Kelliher MA.
    Oncogene; 2011 Mar 10; 30(10):1252-60. PubMed ID: 21057528
    [Abstract] [Full Text] [Related]

  • 6. The Hematopoietic Stem and Progenitor Cell Cistrome: GATA Factor-Dependent cis-Regulatory Mechanisms.
    Hewitt KJ, Johnson KD, Gao X, Keles S, Bresnick EH.
    Curr Top Dev Biol; 2016 Mar 10; 118():45-76. PubMed ID: 27137654
    [Abstract] [Full Text] [Related]

  • 7. Elucidation of the role of LMO2 in human erythroid cells.
    Inoue A, Fujiwara T, Okitsu Y, Katsuoka Y, Fukuhara N, Onishi Y, Ishizawa K, Harigae H.
    Exp Hematol; 2013 Dec 10; 41(12):1062-76.e1. PubMed ID: 24041784
    [Abstract] [Full Text] [Related]

  • 8. Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation.
    Xu Z, Huang S, Chang LS, Agulnick AD, Brandt SJ.
    Mol Cell Biol; 2003 Nov 10; 23(21):7585-99. PubMed ID: 14560005
    [Abstract] [Full Text] [Related]

  • 9. Distinct Ldb1/NLI complexes orchestrate γ-globin repression and reactivation through ETO2 in human adult erythroid cells.
    Kiefer CM, Lee J, Hou C, Dale RK, Lee YT, Meier ER, Miller JL, Dean A.
    Blood; 2011 Dec 01; 118(23):6200-8. PubMed ID: 22010104
    [Abstract] [Full Text] [Related]

  • 10. Forced FOG1 expression in erythroleukemia cells: Induction of erythroid genes and repression of myelo-lymphoid transcription factor PU.1.
    Fujiwara T, Sasaki K, Saito K, Hatta S, Ichikawa S, Kobayashi M, Okitsu Y, Fukuhara N, Onishi Y, Harigae H.
    Biochem Biophys Res Commun; 2017 Apr 01; 485(2):380-387. PubMed ID: 28216155
    [Abstract] [Full Text] [Related]

  • 11. Role of transcriptional corepressor ETO2 in erythroid cells.
    Fujiwara T, Alqadi YW, Okitsu Y, Fukuhara N, Onishi Y, Ishizawa K, Harigae H.
    Exp Hematol; 2013 Mar 01; 41(3):303-15.e1. PubMed ID: 23127762
    [Abstract] [Full Text] [Related]

  • 12. SCL assembles a multifactorial complex that determines glycophorin A expression.
    Lahlil R, Lécuyer E, Herblot S, Hoang T.
    Mol Cell Biol; 2004 Feb 01; 24(4):1439-52. PubMed ID: 14749362
    [Abstract] [Full Text] [Related]

  • 13. Ldb1 complexes: the new master regulators of erythroid gene transcription.
    Love PE, Warzecha C, Li L.
    Trends Genet; 2014 Jan 01; 30(1):1-9. PubMed ID: 24290192
    [Abstract] [Full Text] [Related]

  • 14. The transcription factors Scl and Lmo2 act together during development of the hemangioblast in zebrafish.
    Patterson LJ, Gering M, Eckfeldt CE, Green AR, Verfaillie CM, Ekker SC, Patient R.
    Blood; 2007 Mar 15; 109(6):2389-98. PubMed ID: 17090656
    [Abstract] [Full Text] [Related]

  • 15. Multiple functions of Ldb1 required for beta-globin activation during erythroid differentiation.
    Song SH, Kim A, Ragoczy T, Bender MA, Groudine M, Dean A.
    Blood; 2010 Sep 30; 116(13):2356-64. PubMed ID: 20570862
    [Abstract] [Full Text] [Related]

  • 16. The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation.
    Visvader JE, Mao X, Fujiwara Y, Hahm K, Orkin SH.
    Proc Natl Acad Sci U S A; 1997 Dec 09; 94(25):13707-12. PubMed ID: 9391090
    [Abstract] [Full Text] [Related]

  • 17. Expression of the leukemia oncogene Lmo2 is controlled by an array of tissue-specific elements dispersed over 100 kb and bound by Tal1/Lmo2, Ets, and Gata factors.
    Landry JR, Bonadies N, Kinston S, Knezevic K, Wilson NK, Oram SH, Janes M, Piltz S, Hammett M, Carter J, Hamilton T, Donaldson IJ, Lacaud G, Frampton J, Follows G, Kouskoff V, Göttgens B.
    Blood; 2009 Jun 04; 113(23):5783-92. PubMed ID: 19171877
    [Abstract] [Full Text] [Related]

  • 18. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
    Gering M, Yamada Y, Rabbitts TH, Patient RK.
    Development; 2003 Dec 04; 130(25):6187-99. PubMed ID: 14602685
    [Abstract] [Full Text] [Related]

  • 19. SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.
    Hoang T, Lambert JA, Martin R.
    Curr Top Dev Biol; 2016 Dec 04; 118():163-204. PubMed ID: 27137657
    [Abstract] [Full Text] [Related]

  • 20. Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.
    Deleuze V, El-Hajj R, Chalhoub E, Dohet C, Pinet V, Couttet P, Mathieu D.
    PLoS One; 2012 Dec 04; 7(7):e40484. PubMed ID: 22792348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.